Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M. et al.
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 study group.

J Clin Oncol 2005;
23: 4265-74

Bibliographische Angaben herunterladen

Aufrufen in: